Liquidia Corp (LQDA)
12.53
+0.16
(+1.29%)
USD |
NASDAQ |
Apr 26, 16:00
12.53
0.00 (0.00%)
After-Hours: 20:00
Liquidia Profit Margin (Quarterly): -605.8% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -605.8% |
September 30, 2023 | -429.3% |
June 30, 2023 | -491.4% |
March 31, 2023 | -261.4% |
December 31, 2022 | -121.9% |
September 30, 2022 | -287.3% |
June 30, 2022 | -241.1% |
March 31, 2022 | -456.6% |
December 31, 2021 | -359.7% |
September 30, 2021 | -229.0% |
June 30, 2021 | -194.1% |
March 31, 2021 | -297.8% |
December 31, 2020 | -2.17K% |
September 30, 2020 |
Date | Value |
---|---|
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | -73.11% |
March 31, 2019 | |
December 31, 2018 | -1.70K% |
September 30, 2018 | -5.70K% |
June 30, 2018 | -601.1% |
March 31, 2018 | -2.97K% |
December 31, 2017 | |
September 30, 2017 | -1.06K% |
June 30, 2017 | -418.3% |
March 31, 2017 | -600.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.17K%
Minimum
Dec 2020
-73.11%
Maximum
Jun 2019
-444.5%
Average
-292.5%
Median
Profit Margin (Quarterly) Benchmarks
United Therapeutics Corp | 35.32% |
AIM ImmunoTech Inc | -19.35K% |
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | -57.64% |
Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -119.7% |
Return on Assets | -64.38% |
Return on Invested Capital | -112.8% |
Gross Profit Margin (Quarterly) | 78.08% |
Operating Margin (Quarterly) | -583.4% |
Return on Net Operating Assets | -440.6% |